Intelligent Bio Solutions Stock Current Ratio
| INBS Stock | USD 1.48 0.01 0.68% |
Fundamental analysis of Intelligent Bio allows traders to better anticipate movements in Intelligent Bio's stock price by examining its financial health and performance throughout various phases of its business cycle.
Intelligent | Build AI portfolio with Intelligent Stock |
Intelligent Bio Solutions Company Current Ratio Analysis
Intelligent Bio's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Intelligent Bio Current Ratio | 2.33 X |
Most of Intelligent Bio's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelligent Bio Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Intelligent Bio Solutions has a Current Ratio of 2.33 times. This is 19.93% lower than that of the Health Care Equipment & Supplies sector and 47.76% lower than that of the Health Care industry. The current ratio for all United States stocks is 7.87% lower than that of the firm.
Intelligent Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Bio's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics of similar companies.Intelligent Bio is currently under evaluation in current ratio category among its peers.
Intelligent Fundamentals
| Return On Equity | -1.93 | ||||
| Return On Asset | -0.59 | ||||
| Operating Margin | (3.41) % | ||||
| Current Valuation | 10.19 M | ||||
| Shares Outstanding | 7.43 M | ||||
| Shares Owned By Insiders | 1.05 % | ||||
| Shares Owned By Institutions | 7.98 % | ||||
| Number Of Shares Shorted | 537.78 K | ||||
| Price To Book | 3.65 X | ||||
| Price To Sales | 4.32 X | ||||
| Revenue | 3.05 M | ||||
| Gross Profit | 1.25 M | ||||
| EBITDA | (9.34 M) | ||||
| Net Income | (10.57 M) | ||||
| Cash And Equivalents | 8.28 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 281.81 K | ||||
| Current Ratio | 2.33 X | ||||
| Book Value Per Share | 0.41 X | ||||
| Cash Flow From Operations | (9.68 M) | ||||
| Short Ratio | 2.12 X | ||||
| Earnings Per Share | (2.00) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 53 | ||||
| Beta | 4.59 | ||||
| Market Capitalization | 13.2 M | ||||
| Total Asset | 8.25 M | ||||
| Retained Earnings | (62.53 M) | ||||
| Working Capital | (1.21 M) | ||||
| Net Asset | 8.25 M |
About Intelligent Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.